Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Thran

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Plant Journal : for Cell and Molecular Biology|May 30, 2012
The Arabidopsis DCP2 gene is required for proper mRNA turnover and prevents transgene silencing in ArabidopsisMoritz Thran, Katrin Link, Uwe Sonnewald
Cellular and Molecular Life Sciences : CMLS|October 19, 2018
mRNA as novel technology for passive immunotherapyThomas Schlake, Andreas Thess, Moritz Thran, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2019
mRNA: A Novel Avenue to Antibody Therapy?Thomas Schlake, Moritz Thran, Katja Fiedler, et al.
Scientific Reports|September 5, 2023
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodiesMoritz Thran, Marion Pönisch, Hillary Danz, et al.
Vaccines|August 26, 2022
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody ResponsesNicole Roth, Jacob Schön, Donata Hoffmann, et al.
EMBO Molecular Medicine|August 11, 2017
mRNA mediates passive vaccination against infectious agents, toxins, and tumorsMoritz Thran, Jean Mukherjee, Marion Pönisch, et al.
Nature Communications|July 1, 2021
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2Donata Hoffmann, Björn Corleis, Susanne Rauch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Plant Journal : for Cell and Molecular Biology|May 30, 2012
The Arabidopsis DCP2 gene is required for proper mRNA turnover and prevents transgene silencing in ArabidopsisMoritz Thran, Katrin Link, Uwe Sonnewald
Cellular and Molecular Life Sciences : CMLS|October 19, 2018
mRNA as novel technology for passive immunotherapyThomas Schlake, Andreas Thess, Moritz Thran, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2019
mRNA: A Novel Avenue to Antibody Therapy?Thomas Schlake, Moritz Thran, Katja Fiedler, et al.
Scientific Reports|September 5, 2023
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodiesMoritz Thran, Marion Pönisch, Hillary Danz, et al.
Vaccines|August 26, 2022
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody ResponsesNicole Roth, Jacob Schön, Donata Hoffmann, et al.
EMBO Molecular Medicine|August 11, 2017
mRNA mediates passive vaccination against infectious agents, toxins, and tumorsMoritz Thran, Jean Mukherjee, Marion Pönisch, et al.
Nature Communications|July 1, 2021
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2Donata Hoffmann, Björn Corleis, Susanne Rauch, et al.
Pageof 1